BiotechTube
Home/Arbutus Biopharma/Andrew J. Sung
AJ

Andrew J. Sung

General Counsel

Arbutus Biopharma

Therapeutic Areas

Infectious DiseaseHepatology

Arbutus Biopharma Pipeline

DrugIndicationPhase
Imdusiran (AB-729)Chronic Hepatitis B (cHBV)Phase 2
AB-101Chronic Hepatitis B (cHBV)Phase 2
Combination Regimens (Imdusiran-based)Chronic Hepatitis B (cHBV)Phase 2
AB-161Chronic Hepatitis B (cHBV)Phase 1

Leadership Team at Arbutus Biopharma

LA
Lindsay Androski
President, CEO and Chairperson
TN
Tuan Nguyen
Chief Financial Officer
View full Arbutus Biopharma profile